These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1830013)

  • 41. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
    Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
    Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.
    Lanzone A; Fulghesu AM; Pappalardo S; Proto C; Le Donne M; Andreani CL; Muscatello R; Caruso A; Mancuso S
    Gynecol Obstet Invest; 1990; 29(2):149-53. PubMed ID: 2110544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome.
    Grulet H; Hecart AC; Delemer B; Gross A; Sulmont V; Leutenegger M; Caron J
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):621-6. PubMed ID: 8334748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women.
    Maccario M; Mazza E; Ramunni J; Oleandri SE; Savio P; Grottoli S; Rossetto R; Procopio M; Gauna C; Ghigo E
    Clin Endocrinol (Oxf); 1999 May; 50(5):595-600. PubMed ID: 10468925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Ehrmann DA; Cavaghan MK; Imperial J; Sturis J; Rosenfield RL; Polonsky KS
    J Clin Endocrinol Metab; 1997 Feb; 82(2):524-30. PubMed ID: 9024248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
    Dunaif A; Segal KR; Futterweit W; Dobrjansky A
    Diabetes; 1989 Sep; 38(9):1165-74. PubMed ID: 2670645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
    Holte J; Bergh T; Berne C; Wide L; Lithell H
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2586-93. PubMed ID: 7673399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1508-12. PubMed ID: 16464947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin resistance in nonobese patients with polycystic ovarian disease.
    Chang RJ; Nakamura RM; Judd HL; Kaplan SA
    J Clin Endocrinol Metab; 1983 Aug; 57(2):356-9. PubMed ID: 6223044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
    Lanzone A; Fulghesu AM; Guido M; Fortini A; Caruso A; Mancuso S
    Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.
    Yildiz BO; Woods KS; Stanczyk F; Bartolucci A; Azziz R
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5558-62. PubMed ID: 15531511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.
    Sharp PS; Kiddy DS; Reed MJ; Anyaoku V; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1991 Sep; 35(3):253-7. PubMed ID: 1742883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.
    Dunaif A; Segal KR; Shelley DR; Green G; Dobrjansky A; Licholai T
    Diabetes; 1992 Oct; 41(10):1257-66. PubMed ID: 1397698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
    Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
    J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome.
    Ciaraldi TP; el-Roeiy A; Madar Z; Reichart D; Olefsky JM; Yen SS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):577-83. PubMed ID: 1322430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women.
    Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1990 Sep; 71(3):696-704. PubMed ID: 2144295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
    Yucel A; Noyan V; Sagsoz N
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
    Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
    J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.